These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 20628234)
21. SCN9A variant in a family of mixed breed dogs with congenital insensitivity to pain. Gutierrez-Quintana R; Christen M; Faller KME; Guevar J; Jagannathan V; Leeb T J Vet Intern Med; 2023 Jan; 37(1):230-235. PubMed ID: 36630088 [TBL] [Abstract][Full Text] [Related]
22. [Novel compound heterozygous SCN9A variations causing congenital insensitivity to pain in a patient]. Bai Y; Sun Y; Wu J; Liu N; Jiao Z; Li Q; Zhao K; Kong X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Apr; 39(4):392-396. PubMed ID: 35446973 [TBL] [Abstract][Full Text] [Related]
23. Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling. Remacle AG; Kumar S; Motamedchaboki K; Cieplak P; Hullugundi S; Dolkas J; Shubayev VI; Strongin AY J Biol Chem; 2015 Sep; 290(38):22939-44. PubMed ID: 26283785 [TBL] [Abstract][Full Text] [Related]
24. Ocular manifestations among patients with congenital insensitivity to pain due to variants in PRDM12 and SCN9A genes. Elsana B; Imtirat A; Yagev R; Gradstein L; Majdalani P; Iny O; Parvari R; Tsumi E Am J Med Genet A; 2022 Dec; 188(12):3463-3468. PubMed ID: 36111846 [TBL] [Abstract][Full Text] [Related]
25. Congenital insensitivity to pain: a novel mutation affecting a U12-type intron causes multiple aberrant splicing of SCN9A. Marchi M; D'Amato I; Andelic M; Cartelli D; Salvi E; Lombardi R; Gumus E; Lauria G Pain; 2022 Jul; 163(7):e882-e887. PubMed ID: 34799533 [TBL] [Abstract][Full Text] [Related]
26. Defining the Functional Role of Na McDermott LA; Weir GA; Themistocleous AC; Segerdahl AR; Blesneac I; Baskozos G; Clark AJ; Millar V; Peck LJ; Ebner D; Tracey I; Serra J; Bennett DL Neuron; 2019 Mar; 101(5):905-919.e8. PubMed ID: 30795902 [TBL] [Abstract][Full Text] [Related]
27. Molecular genetic analysis in 21 Chinese families with congenital insensitivity to pain with or without anhidrosis. Zhao F; Mao B; Geng X; Ren X; Wang Y; Guan Y; Li S; Li L; Zhang S; You Y; Cao Y; Yang T; Zhao X Eur J Neurol; 2020 Aug; 27(8):1697-1705. PubMed ID: 32219930 [TBL] [Abstract][Full Text] [Related]
28. Understanding the genetic basis of congenital insensitivity to pain. Drissi I; Woods WA; Woods CG Br Med Bull; 2020 May; 133(1):65-78. PubMed ID: 32219415 [TBL] [Abstract][Full Text] [Related]
29. Charcot ankle, congenital insensitivity to pain and a mutation in the SCN9A gene. Chen Z; Zhang H; Dai SM QJM; 2022 Jul; 115(7):469-470. PubMed ID: 35512413 [No Abstract] [Full Text] [Related]
30. A life without pain: congenital insensitivity to pain due to compound heterozygous SCN9A mutation. Ma A; Turner A J Paediatr Child Health; 2012 Mar; 48(3):285-6. PubMed ID: 22417470 [No Abstract] [Full Text] [Related]
31. Congenital insensitivity to pain: Fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in SCN11A encoding voltage-gated sodium channel 1.9. Phatarakijnirund V; Mumm S; McAlister WH; Novack DV; Wenkert D; Clements KL; Whyte MP Bone; 2016 Mar; 84():289-298. PubMed ID: 26746779 [TBL] [Abstract][Full Text] [Related]
32. SCN9A-associated congenital insensitivity to pain and anosmia in an Irish patient. Bogdanova-Mihaylova P; Alexander MD; Murphy RP; Murphy SM J Peripher Nerv Syst; 2015 Jun; 20(2):86-7. PubMed ID: 26292973 [No Abstract] [Full Text] [Related]
33. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors. Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756 [TBL] [Abstract][Full Text] [Related]
35. [Pain and analgesia : Mutations of voltage-gated sodium channels]. Eberhardt MJ; Leffler A Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262 [TBL] [Abstract][Full Text] [Related]
36. Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A. Drenth JP; Te Morsche RH; Mansour S; Mortimer PS Arch Dermatol; 2008 Mar; 144(3):320-4. PubMed ID: 18347287 [TBL] [Abstract][Full Text] [Related]
37. Rare mutations in ATL3, SPTLC2 and SCN9A explaining hereditary sensory neuropathy and congenital insensitivity to pain in a Brazilian cohort. Cintra VP; Dohrn MF; Tomaselli PJ; Figueiredo FB; Marques SE; Camargos ST; Barbosa LSM; P Rebelo A; Abreu L; Danzi M; Marques W; Züchner S J Neurol Sci; 2021 Aug; 427():117498. PubMed ID: 34090020 [TBL] [Abstract][Full Text] [Related]
38. Two novel SCN9A mutations causing insensitivity to pain. Nilsen KB; Nicholas AK; Woods CG; Mellgren SI; Nebuchennykh M; Aasly J Pain; 2009 May; 143(1-2):155-8. PubMed ID: 19304393 [TBL] [Abstract][Full Text] [Related]
39. No mutations in the voltage-gated NaV1.7 sodium channel alpha1 subunit gene SCN9A in familial complex regional pain syndrome. de Rooij AM; Gosso MF; Alsina-Sanchis E; Marinus J; van Hilten JJ; van den Maagdenberg AM Eur J Neurol; 2010 Jun; 17(6):808-14. PubMed ID: 20074229 [TBL] [Abstract][Full Text] [Related]